SCHEDULE 13G/A: Valor Entities Maintain Significant Stake in Harmony Biosciences, Disclosing 11.7% Beneficial Ownership

Valor IV Pharma Holdings, LLC and affiliated entities, including Antonio J. Gracias and Juan A. Sabater, have filed an amended Schedule 13G disclosing a collective beneficial ownership of up to 11.7% of Harmony Biosciences Holdings, Inc. common stock as of December 31, 2024.

Summary

• Valor IV Pharma Holdings, LLC and its affiliated entities, including Valor Equity Partners IV L.P., Valor Equity Partners IV-A L.P., Valor Equity Partners IV-B L.P., Valor Equity Associates IV L.P., Valor Equity Capital IV LLC, and Valor Management L.P., collectively reported beneficial ownership of 6,618,033 shares of Harmony Biosciences Holdings, Inc. common stock.
• This collective ownership represents 11.6% of the outstanding common stock as of December 31, 2024.
• Antonio J. Gracias reported beneficial ownership of 6,654,747 shares, representing 11.7% of the class, which includes 36,714 shares with sole voting and dispositive power and 6,618,033 shares with shared voting and dispositive power.
• Juan A. Sabater reported beneficial ownership of 6,644,257 shares, representing 11.6% of the class, which includes 26,224 shares with sole voting and dispositive power and 6,618,033 shares with shared voting and dispositive power.
• The percentage of class is calculated based on 57,031,297 shares of common stock outstanding as of October 25, 2024, as previously reported by Harmony Biosciences in its Form 10-Q filed on October 29, 2024.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Management Comments

• Antonio J. Gracias and Juan A. Sabater disclaim beneficial ownership of the shares held of record by Valor IV Pharma Holdings, LLC for purposes of Sections 13(d) or 13(g) of the Act, despite potentially being deemed to share beneficial ownership by virtue of their positions with Valor Management L.P.

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor and does not provide broader industry analysis or context.

Related Party Transactions

• Valor Management L.P. is the managing member of Valor Equity Capital IV LLC.
• Valor Equity Capital IV LLC is the general partner of Valor Equity Associates IV L.P.
• Valor Equity Associates IV L.P. is the general partner of Valor Equity Partners IV L.P., Valor Equity Partners IV-A L.P., and Valor Equity Partners IV-B L.P.
• The Valor Funds (Valor Equity Partners IV L.P., IV-A L.P., IV-B L.P.) are the sole members of Valor IV Pharma Holdings, LLC.
• Antonio J. Gracias and Juan A. Sabater are associated with Valor Management L.P. and may be deemed to share beneficial ownership through this complex organizational structure.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can influence market perception and trading activity.
• Company Management: Awareness of a large, potentially influential shareholder group and their continued investment in the company.

Key Dates

Keywords

Harmony Biosciences Holdings Inc, Valor IV Pharma Holdings LLC, Valor Equity Partners, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Equity Stake, Antonio J. Gracias, Juan A. Sabater